PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio

PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio

Malaysia rolled out a diverse portfolio of predominantly three COVID-19 vaccines (AZD1222, BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine effectiveness with two methods, covering 1 April to 15 September 2021: (1) the screening method for COVID-19 (SARS-CoV-2) infection and...

Full description

Bibliographic Details
Main Authors: Jing Lian Suah, Peter Seah Keng Tok, Su Miin Ong, Masliyana Husin, Boon Hwa Tng, Sheamini Sivasampu, Thevesh Thevananthan, Maheshwara Rao Appannan, Faizah Muhamad Zin, Shahanizan Mohd Zin, Hazlina Yahaya, Norhayati Rusli, Mohd Fikri Ujang, Hishamshah Mohd Ibrahim, Noor Hisham Abdullah, Kalaiarasu M. Peariasamy
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
COVID-19 vaccines
vaccine effectiveness
cohort study
Malaysia
Online Access:https://www.mdpi.com/2076-393X/9/12/1381

Internet

https://www.mdpi.com/2076-393X/9/12/1381

Similar Items